These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 30407746)

  • 1. Model Informed Drug Development and Regulation in China: Challenges and Opportunities.
    Li L; Han H; Wang J; Wei C; Wang Y; Li M; Zhou Y; Yang J
    CPT Pharmacometrics Syst Pharmacol; 2019 Feb; 8(2):59-61. PubMed ID: 30407746
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent Advances in Drug Development and Regulatory Science in China.
    Chen J; Zhao N
    Ther Innov Regul Sci; 2018 Nov; 52(6):739-750. PubMed ID: 29714583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Procrustean pathways for complex generic drugs development.
    Cristofoletti R; Schmidt S; Diniz A
    Ther Deliv; 2018 Sep; 9(9):605-607. PubMed ID: 30189807
    [No Abstract]   [Full Text] [Related]  

  • 4. Generating Model Integrated Evidence for Generic Drug Development and Assessment.
    Zhao L; Kim MJ; Zhang L; Lionberger R
    Clin Pharmacol Ther; 2019 Feb; 105(2):338-349. PubMed ID: 30414386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Regulators Talking to Each Other Across Borders?
    van der Graaf PH
    Clin Pharmacol Ther; 2020 Mar; 107(3):481-483. PubMed ID: 32048286
    [No Abstract]   [Full Text] [Related]  

  • 6. Iberoamerican Pharmacometrics Network Congress 2018 Report: Fostering Modeling and Simulation Approaches for Drug Development and Regulatory and Clinical Applications in Latin America.
    Ibarra M; Dalla Costa T; Schaiquevich P; Cristofoletti R; Hernández González I; Fajardo-Robledo NS; Aragón Novoa M; Pecchio M; Cortinez I; Trocóniz IF; Romero-Tejeda EM
    CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):197-200. PubMed ID: 30681295
    [No Abstract]   [Full Text] [Related]  

  • 7. Model-Informed Drug Discovery and Development: Current Industry Good Practice and Regulatory Expectations and Future Perspectives.
    Marshall S; Madabushi R; Manolis E; Krudys K; Staab A; Dykstra K; Visser SAG
    CPT Pharmacometrics Syst Pharmacol; 2019 Feb; 8(2):87-96. PubMed ID: 30411538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining orphan conditions in the context of the European orphan regulation: challenges and evolution.
    O'Connor DJ; Sheean ME; Hofer MP; Tsigkos S; Mariz S; Fregonese L; Larsson K; Hivert V; Westermark K; Naumann-Winter F; Stoyanova-Beninska V; Barišić I; Capovilla G; Magrelli A; Sepodes B
    Nat Rev Drug Discov; 2019 Jul; 18(7):479-480. PubMed ID: 30940922
    [No Abstract]   [Full Text] [Related]  

  • 9. Applications of Adaptive Designs in Generic Drug Development.
    Lee J; Feng K; Xu M; Gong X; Sun W; Kim J; Zhang Z; Wang M; Fang L; Zhao L
    Clin Pharmacol Ther; 2021 Jul; 110(1):32-35. PubMed ID: 32940349
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory density as a means to refine current regulatory approaches for increasingly complex medicines.
    Klein K; Stolk P; De Bruin ML; Leufkens H
    Drug Discov Today; 2021 Oct; 26(10):2221-2225. PubMed ID: 33862191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Opportunities With Oncology Drug Development in China.
    Bajaj G; Gupta M; Wang HH; Barrett JS; Tan M; Rupalla K; Bertz R; Sheng J
    Clin Pharmacol Ther; 2019 Feb; 105(2):363-375. PubMed ID: 29328503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMEA tackles "generic" biologic drug issues.
    Rice M
    J Natl Cancer Inst; 2006 Apr; 98(7):435-6. PubMed ID: 16595776
    [No Abstract]   [Full Text] [Related]  

  • 13. Reforming the Orphan Drug Act for the 21st Century.
    Sarpatwari A; Kesselheim AS
    N Engl J Med; 2019 Jul; 381(2):106-108. PubMed ID: 31291512
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis.
    Bell C; Anderson J; Ganguly T; Prescott J; Capila I; Lansing JC; Sachleben R; Iyer M; Fier I; Roach J; Storey K; Miller P; Hall S; Kantor D; Greenberg BM; Nair K; Glajch J
    J Pharm Pract; 2018 Oct; 31(5):481-488. PubMed ID: 28847230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The consequences of 'Brexit' for drug discovery and development, and the regulatory implications.
    Golding BT; Waring MJ
    Expert Opin Drug Discov; 2018 Jul; 13(7):583-585. PubMed ID: 29634365
    [No Abstract]   [Full Text] [Related]  

  • 16. Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.
    Khullar D; Ohn JA; Trusheim M; Bach PB
    N Engl J Med; 2020 Jan; 382(5):473-480. PubMed ID: 31995697
    [No Abstract]   [Full Text] [Related]  

  • 17. Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility.
    Musuamba FT; Skottheim Rusten I; Lesage R; Russo G; Bursi R; Emili L; Wangorsch G; Manolis E; Karlsson KE; Kulesza A; Courcelles E; Boissel JP; Rousseau CF; Voisin EM; Alessandrello R; Curado N; Dall'ara E; Rodriguez B; Pappalardo F; Geris L
    CPT Pharmacometrics Syst Pharmacol; 2021 Aug; 10(8):804-825. PubMed ID: 34102034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13th EGA annual conference. Challenges in the European and global environment for the generic medicines industry.
    Kuhrt K
    IDrugs; 2007 Aug; 10(8):549-53. PubMed ID: 17665329
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent US Food and Drug Administration Efforts to Integrate the Patient's Perspective in Drug Development and Decision Making.
    Mullin T; Vaidya P; Chalasani M
    Clin Pharmacol Ther; 2019 Apr; 105(4):789-791. PubMed ID: 30609017
    [No Abstract]   [Full Text] [Related]  

  • 20. Abbreviated New Drug Applications: Generic Drug User Fee Amendments Act Analysis of Application Quality Metrics.
    Woo J; Luan JJ; Li Z; Grosser S; Peters J; Chazin H
    Ther Innov Regul Sci; 2019 Sep; 53(5):696-700. PubMed ID: 30360656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.